EP Patent

EP1465872A1 — 4-sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor

Assigned to Bayer Pharmaceuticals Corp · Expires 2004-10-13 · 22y expired

What this patent protects

Disclosed are 4-sulfide / sulfoxide / sulfonyl-1H-pyrazolyl derivative compounds of formulas (I) or (II):wherein the variables n, R, R1, R2, R3, R3', R4, R4', R5 and R6 are as defined in the specification. The compounds are useful for the treatment or prevention of diseases and/o…

USPTO Abstract

Disclosed are 4-sulfide / sulfoxide / sulfonyl-1H-pyrazolyl derivative compounds of formulas (I) or (II):wherein the variables n, R, R1, R2, R3, R3', R4, R4', R5 and R6 are as defined in the specification. The compounds are useful for the treatment or prevention of diseases and/or behaviors involving the 5-HT2C receptor.

Drugs covered by this patent

Patent Metadata

Patent number
EP1465872A1
Jurisdiction
EP
Classification
—
Expires
2004-10-13
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Pharmaceuticals Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.